Mavoglurant is under development for the treatment of cocaine use disorder, alcohol use disorder and for language learning in young children with fragile X syndrome (FXS). The drug candidate is ...
PORTLAND, OR / ACCESSWIRE / December 23, 2024 / Kaya Holdings, Inc. (OTCQB:KAYS) and The Sacred MushroomTM, Portland's one-of-a-kind psilocybin treatment center, are excited to announce their first Op ...
'The holiday season can make it harder for people to think clearly and make decisions, often adding pressure that worsens ADHD symptoms,' says Valerie Snyder, Mental Wellness Coach at Mentavi Health. ...